Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/12/1991 | US4999299 Plant cells |
03/12/1991 | US4999296 Thymidine kinase negative insertion mutants of pseudorabies virus and methods for the production of same |
03/12/1991 | US4999294 Purifying, digesting, ligating DNA; transforming and trans-ferring cloned DNA vector into Escherichia; screening, isolat-ing DNA coding; culturing host cell with vector |
03/12/1991 | US4999293 Genetic engineering; insertion into host, fermentation, purification |
03/12/1991 | US4999292 Bacteria that metabolize phenylacetate through mandelate |
03/12/1991 | US4999291 Production of human pluripotent granulocyte colony-stimulating factor |
03/12/1991 | CA2066576A1 Method and apparatus for the production of tgf-beta and purified tgf-beta compositions |
03/12/1991 | CA2065866A1 Production of growth hormone in transgenic animal milk |
03/12/1991 | CA2024277A1 Screening methods for protease inhibitors |
03/12/1991 | CA1281287C Protection of equines against streptococcus equi |
03/09/1991 | WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas |
03/09/1991 | WO1991003483A1 Tsh receptor |
03/09/1991 | CA2024918A1 Fused proteins and production thereof |
03/08/1991 | WO1991003555A1 Interleukin-4 receptors |
03/08/1991 | CA2066240A1 Interleukin-4 receptors |
03/08/1991 | CA2024720A1 Rna with endoribonuclease activity for mrna of ripening genes, the preparation thereof and the use thereof in plants |
03/08/1991 | CA2024697A1 Protein having anticoagulant properties |
03/07/1991 | WO1991002817A1 Quantitation of nucleic acids using the polymerase chain reaction |
03/07/1991 | WO1991002807A1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
03/07/1991 | WO1991002805A2 Recombinant retroviruses delivering vector constructs to target cells |
03/07/1991 | WO1991002804A1 Recombinant adenovirus sequence expressing rhabdovirus antigen and use as a vaccine |
03/07/1991 | WO1991002803A1 A method of suppressing chromosomal gene expression |
03/07/1991 | WO1991002802A1 Hybrid plasmids for the production of subtilisin carlsberg in bacillus |
03/07/1991 | WO1991002801A1 An in vitro packaging system for cloning dna fragments of 95 kb |
03/07/1991 | WO1991002798A2 t-PA MUTANT GK1L |
03/07/1991 | WO1991002797A1 Cell lineages infectable by a retrovirus and containing a marker activated by the infection |
03/07/1991 | WO1991002796A1 Cystic fibrosis gene |
03/07/1991 | WO1991002793A1 Cardiomyopathic transgenic non-human mammal |
03/07/1991 | WO1991002792A1 Alkaline proteolytic enzyme and method of production |
03/07/1991 | WO1991002790A1 Enzymes which participate in c-terminal amidation, and production and use thereof |
03/07/1991 | WO1991002788A1 Herpes simplex virus type 1 mutant |
03/07/1991 | WO1991002756A1 Prohormone cleavage site blocking antibody |
03/07/1991 | WO1991002754A1 Fusion proteins comprising gm-csf and il-3 |
03/07/1991 | WO1991002753A1 Anticoagulant protein |
03/07/1991 | WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
03/07/1991 | WO1991002748A1 Rubella e1 peptides |
03/07/1991 | WO1991002735A1 Chemical compounds based on a netropsin or distamycin molecule coupled with an intercalating agent, method for preparing said compounds and pharmaceutical compositions containing same |
03/07/1991 | WO1991002544A1 Composition containing a b epitope of the envelope glycoprotein of a retrovirus and a t epitope of a protein which is distinct from this virus |
03/07/1991 | WO1991000920A3 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
03/07/1991 | DE3929030A1 Verfahren zur vermehrung von nukleinsaeuren A method for amplification of nucleic acids |
03/07/1991 | DE3928861A1 Monoclonal antibodies specific for interleukin 8 - reagents for quantitative sandwich ELISA and affinity purificn. |
03/07/1991 | CA2039174A1 Enzyme participating in c-terminal amidation, and method of preparing same and use thereof |
03/07/1991 | CA2039141A1 Composition resulting from the combination of the glycoprotein coat epitoque b of a type iv retrovirus and of an epitope t from a separate protein coded with this retrovirus, and their application for the production of protectors c antibodies for aids |
03/06/1991 | EP0415755A2 Process for controlling contamination of oligonucleotide-dependent nucleic acid amplification reactions |
03/06/1991 | EP0415731A2 Novel entities for cancer therapy |
03/06/1991 | EP0415565A2 Enhanced expression of heterologous proteins in recombinant hosts in a non-growth media |
03/06/1991 | EP0415470A2 Aminopeptidase |
03/06/1991 | EP0415296A2 High alkaline proteases |
03/06/1991 | EP0414915A1 New superoxide dismutase |
03/06/1991 | EP0414870A1 Nitrate reductase as marker for filamentous fungi |
03/06/1991 | EP0414812A1 Extraction of human interleukin-4 from bacteria |
03/06/1991 | EP0414809A1 Plant defense gene regulatory elements |
03/06/1991 | EP0414808A1 PROCESS FOR SCREENING AN EXPRESSION cDNA CLONE BANK FOR POLYNUCLEOTIDES. |
03/06/1991 | EP0414807A1 Human mammary cell growth inhibitor and methods of production and use |
03/06/1991 | EP0414728A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO |
03/06/1991 | EP0414713A1 Regulatory cassette for expression vectors |
03/06/1991 | EP0162054B1 Production of cdna representing hepatitis a viral sequences |
03/06/1991 | EP0131623B1 Chimeric genes suitable for expression in plant cells |
03/06/1991 | CN1049668A Process for preparing sequence of antidirection direction, antimessenger rna oligonuclectides of alpha tnf |
03/05/1991 | WO1991003546A1 Arginine-rich yeast |
03/05/1991 | US4997932 Method and kit for purifying nucleic acids |
03/05/1991 | US4997930 Cloning of complementary DNA encoding maize nitrite reductase |
03/05/1991 | US4997929 Genetic engineering |
03/05/1991 | US4997916 Method for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cell |
03/05/1991 | US4997767 Genetic engineering |
03/05/1991 | US4997766 Anticoagulants |
03/05/1991 | US4997763 Vectors for gene insertion into avian germ line |
03/05/1991 | US4997647 Polypeptide |
03/05/1991 | CA2041653A1 Yeast with high content of arginine |
03/05/1991 | CA2024554A1 Process for producing thiamine phosphates |
03/05/1991 | CA2024145A1 Expression plasmids and use thereof |
03/05/1991 | CA1280986C Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same |
03/02/1991 | WO1991003260A1 Antisense oligonucleotides to c-abl proto-oncogene |
03/02/1991 | CA2065294A1 Antisense oligonucleotides to c-abl proto-oncogene |
03/01/1991 | WO1991003738A1 Immunochemical reagents and methods for monitoring industrial fermentation |
03/01/1991 | WO1991003484A1 Abo genotyping |
03/01/1991 | CA2065352A1 Abo genotyping |
03/01/1991 | CA2039178A1 Reactives and immunochemical methods for measuring microorganisms growing and proteins quantity during industrial fermentation |
03/01/1991 | CA2024448A1 Recombinant dna expression system for aspergillus |
03/01/1991 | CA2022762A1 Cloned dna sequences originating from soybean chlorotic mottle virus genome |
02/28/1991 | DE3928046A1 Hybridplasmide zur erzeugung von subtilisin carlsberg in bacillus Hybrid plasmids for the production of subtilisin carlsberg in bacillus |
02/27/1991 | EP0414607A2 Anti-sense nucleotide sequence, anti RNA against alpha TNF messenger RNA, process for the preparation thereof, medical use thereof and its inclusion in pharmaceutical preparations |
02/27/1991 | EP0414551A2 Method for electroporation and buffer used therefor |
02/27/1991 | EP0414475A1 Methods for culturing HCV in eukaryotic cells |
02/27/1991 | EP0414469A2 Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
02/27/1991 | EP0414374A2 Novel antigens and methods for their preparation |
02/27/1991 | EP0414355A1 Feline interferon and process for production thereof by a silkworm virus vector |
02/27/1991 | EP0414297A1 Efficient production of mutant proteases |
02/27/1991 | EP0414247A2 Cloning, expression and sequencing of an ester hydrolase genein escherichia coli |
02/27/1991 | EP0414178A2 Non-human primate CD4 polypeptides and human CD4 molecules capable of being glycosylated |
02/27/1991 | EP0414151A1 Production of human nerve growth factor proteins |
02/27/1991 | EP0414134A1 Method for producing antiviral protein utilizing E.coli transformant, and gene and E.coli vector used in the method |
02/27/1991 | EP0414044A1 Cell treating injection device |
02/27/1991 | EP0414035A2 Gibbon ape leukemia virus receptor |
02/27/1991 | EP0414007A2 A novel arginine deiminase, its manufacturing method and an anti-cancer agent containing this enzyme as an effective ingredient |
02/27/1991 | EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it |
02/27/1991 | EP0413818A1 Process for producing a human neutrophil chemotactic factor polypeptide. |
02/27/1991 | EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
02/27/1991 | EP0413738A1 Vectors encoding hcmv glycoprotein and expression products |
02/27/1991 | EP0413721A1 Human gm-csf variants |